PubRank

M Berrettini

Author PubWeight™ 31.90‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy. Lancet 1996 6.58
2 A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS). J Thromb Haemost 2005 3.47
3 Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: a four-year prospective study from the Italian Registry. Am J Med 1996 2.51
4 Thrombotic events during oral anticoagulant treatment: results of the inception-cohort, prospective, collaborative ISCOAT study: ISCOAT study group (Italian Study on Complications of Oral Anticoagulant Therapy). Thromb Haemost 1997 1.27
5 Purification and characterization of plasma protein C inhibitor. Thromb Res 1989 1.10
6 Activated human protein C prevents thrombin-induced thromboembolism in mice. Evidence that activated protein c reduces intravascular fibrin accumulation through the inhibition of additional thrombin generation. J Clin Invest 1998 0.99
7 Immunoblotting studies of the molecular forms of protein C in plasma. Thromb Res 1988 0.97
8 Autoactivation of human plasma prekallikrein. J Biol Chem 1987 0.96
9 Platelet activation in psoriasis. Thromb Haemost 1985 0.92
10 Molecular mechanisms of FVII deficiency: expression of mutations clustered in the IVS7 donor splice site of factor VII gene. Blood 1998 0.89
11 Detection of in vitro and in vivo cleavage of high molecular weight kininogen in human plasma by immunoblotting with monoclonal antibodies. Blood 1986 0.88
12 Quantitative immunoblotting assay of blood coagulation factor XII. Thromb Res 1986 0.83
13 Enhanced specificity of immunoblotting using radiolabeled antigen overlay: studies of blood coagulation factor XII and prekallikrein in plasma. Anal Biochem 1986 0.82
14 Detection and quantitation of cleaved and uncleaved high molecular weight kininogen in plasma by ligand blotting with radiolabeled plasma prekallikrein or factor XI. Thromb Haemost 1988 0.81
15 Desmopressin-induced improvement of abnormal coagulation in chronic liver disease. Lancet 1983 0.80
16 Exhausted platelets in chronic obstructive pulmonary disease. Respiration 1983 0.80
17 High-molecular weight kininogen is present in cultured human endothelial cells: localization, isolation, and characterization. Blood 1988 0.79
18 Effect of peritoneal dialysis, haemodialysis and kidney transplantation on blood platelet function. I. Platelet aggregation by ADP and epinephrine. Nephron 1979 0.79
19 Effect of DDAVP on plasma level of factor XII. Br J Haematol 1983 0.78
20 Fatty acid pattern of red blood cell membranes and risk of ischemic brain infarction: a case-control study. Stroke 1987 0.78
21 Effects of dipyridamole on the hypoxemic pulmonary hypertension of patients with chronic obstructive pulmonary disease. Respiration 1988 0.78
22 Three abnormal fibrinogen variants with the same amino acid substitution (gamma 275 Arg----His): fibrinogens Bergamo II, Essen and Perugia. Thromb Haemost 1986 0.77
23 Immunoblotting studies of coagulation factor XII, plasma prekallikrein, and high molecular weight kininogen. Semin Thromb Hemost 1987 0.77
24 Quantitative immunoblotting of plasma and platelet protein S. Thromb Haemost 1986 0.75
25 Biphasic sulphinpyrazone-warfarin interaction. Br Med J (Clin Res Ed) 1981 0.75
26 Clinical problem-solving: decision making by analogy. N Engl J Med 1995 0.75
27 Clofibrate-induced myocardial injury and disseminated intravascular coagulation in a patient with chronic renal failure. Panminerva Med 1984 0.75
28 Inhibition of spontaneous platelet aggregation and adhesion by indobufen (K 3920). A randomized, double-blind crossover study on platelet, coagulation and fibrinolysis function tests. Pharmatherapeutica 1982 0.75
29 [Optimization of a method for determining platelet malondialdehyde production]. Boll Soc Ital Biol Sper 1983 0.75
30 Enhanced plasma beta-thromboglobulin in hypoxemia: effect of dipyridamole. N Engl J Med 1981 0.75
31 Disseminated intravascular coagulation in dissecting aortic aneurysm. A case report. Panminerva Med 1981 0.75
32 Failure to demonstrate beneficial effect of prostacyclin (PGI2) infusion on red blood cell deformability in patients with peripheral vascular disease: a possible role of the leukocytes. Angiology 1992 0.75
33 Polyacrilonytrile versus cuprophan membranes for hemodialysis: evaluation of efficacy and biocompatibility by platelet aggregation studies. Int J Artif Organs 1981 0.75
34 Persistent spontaneous heparinaemia in systemic mastocytosis. Folia Haematol Int Mag Klin Morphol Blutforsch 1982 0.75
35 [Acute immunoallergic thrombopenia due to sulfamethoxazole-trimethoprim]. Nouv Presse Med 1980 0.75
36 Platelet malondialdehyde production kinetics after cyclooxygenase block. A study performed with a modified high sensitivity assay. Haemostasis 1983 0.75
37 Tissue factor pathway inhibitor levels in patients with homocystinuria. Thromb Res 2000 0.75
38 Subcutaneous factor IX administration to patients with hemophilia B. Am J Hematol 1994 0.75
39 [In vitro study of the effects of various 4-hydroxyisophthalic acid derivatives on human platelet aggregation]. Boll Soc Ital Biol Sper 1983 0.75
40 Carrier detection in factor VII congenital deficiency. Br J Haematol 1985 0.75
41 [In vitro study of the mechanism of the platelet anti-aggregant action of picotamide (G 137)]. Boll Soc Ital Biol Sper 1983 0.75
42 Inhibition of spontaneous platelet aggregation by sulfinpyrazone. Thromb Haemost 1979 0.75
43 Heparin assay: a comparison between titrimetric and amidolytic methods. Boll Soc Ital Biol Sper 1980 0.75